Katrine Mose, Anton Pottegård, Mette Reilev, Christen Lykkegaard Andersen, Blánaid Hicks, Mathilde Egelund Christensen. Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study. // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70779. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70779?af=R
Katrine Mose, Anton Pottegård, Mette Reilev, Christen Lykkegaard Andersen, Blánaid Hicks, & Mathilde Egelund Christensen (2026). Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study. British Journal of Haematology. https://doi.org/10.1111/bjh.70779
Katrine Mose, et al. “Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study.” British Journal of Haematology, 2026. doi:10.1111/bjh.70779.
@article{Mose2026,
title = {Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study},
author = {Mose, Katrine and Pottegård, Anton and Reilev, Mette and Andersen, Christen Lykkegaard and Hicks, Blánaid and Christensen, Mathilde Egelund},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70779},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70779?af=R}
}